封面
市场调查报告书
商品编码
1629825

全球行动医疗市场 - 2024-2031

Global MHealth Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年,全球行动医疗市场规模达616.5亿美元,预计2031年将达到1,622亿美元,2024-2031年预测期间复合年增长率为12.9%。

mHealth(行动健康)是指行动电话和其他无线技术在医疗保健领域的应用。行动医疗的主要应用之一是透过行动装置向消费者宣传预防性医疗服务。除了教育之外,行动医疗在疾病监测、治疗支援、流行病爆发监测和慢性病管理等各个领域中发挥着至关重要的作用。这种多样化的应用突显了行动技术对增强医疗服务和改善病患治疗效果的重大影响。

市场动态:

驱动程式和限制

增加数位健康解决方案的使用

数位医疗解决方案的使用增加预计将推动行动医疗市场的发展。这是由于技术的不断进步、数位医疗解决方案的增加以及即时结果的不断提高,预计将推动行动医疗市场的成长。远距医疗服务的成长极大地促进了行动医疗解决方案的采用,特别是在高度发达国家和地区。据美国国立卫生研究院2024年4月称,来自美国的数据表明,65岁以上的人中只有38%使用过mHealth应用程式来监测自己的健康状况。

这些数位健康解决方案有助于远端咨询和持续的健康监测,从而提高医疗保健服务的可近性和效率。此外,包括智慧手錶和健身追踪器在内的可穿戴技术的创新,透过实现基本健康指标的即时跟踪,正在扩展行动医疗应用的功能。例如,2023 年10 月,Cedars-Sinai 宣布正在透过一款新的行动应用程式为加州的患者扩展虚拟医疗保健,该应用程式允许个人快速轻鬆地联繫Cedars-Sinai 专家,以提供疾病、慢性病和预防性护理。透过新的虚拟医疗保健选项 Cedars-Sinai Connect,医疗保健专业人员可以 24/7 全天候处理紧急问题,并且可以透过减少等待时间为初级保健提供当天预约。

远距医疗和穿戴式装置的整合正在改变行动医疗市场,使其成为现代医疗保健的重要组成部分,满足不同人群的需求并改善整体健康结果。

随着智慧型手机使用量的不断增长,包括行动医疗解决方案在内的数位健康解决方案的采用预计将会增加。个人对智慧型手机的使用越来越多。例如,根据全球行动互联网连接,预计到 2030 年,行动普及率将增至 63 亿,覆盖全球人口的 74%。

资料隐私和安全问题

应用程式设计漏洞、用户资料保护不足、开发人员知识差距、监管合规性挑战和用户行为引起的资料隐私和安全问题严重阻碍了行动医疗市场的成长。解决这些问题对于培养消费者之间的信任和促进更广泛地采用行动医疗解决方案至关重要。如果没有增强的安全措施和更大的资料处理实务透明度,行动医疗技术的潜在优势可能无法实现。因此,上述因素可能会减少行动医疗解决方案的采用,从而阻碍市场成长。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 增加数位健康解决方案的使用
    • 限制
      • 资料隐私和安全问题
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 报销分析
  • 专利分析
  • SWOT分析
  • DMI 意见

第 6 章:依产品类型

  • 行动医疗应用程式
    • 一般健康与健身应用程式
    • 慢性病管理应用程式
    • 女性健康应用
    • 其他医疗保健应用程式
  • 行动医疗设备
    • 血糖仪
    • 血压计
    • 脉搏血氧仪
    • 神经监视器
    • 心臟监测仪
    • 呼吸暂停和睡眠监测器
    • 其他的

第 7 章:按申请

  • 心血管疾病
  • 糖尿病
  • 胎儿监测
  • 呼吸系统疾病
  • 神经病学
  • 营养与健身
  • 其他的

第 8 章:最终用户

  • 医疗保健提供者
  • 病人/消费者
  • 其他的

第 9 章:按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Medtronic
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • OMRON Healthcare, Inc.
  • AliveCor, Inc.
  • AirStrip Technologies, Inc
  • AgaMatrix
  • F. Hoffmann-La Roche AG
  • Abbott
  • LifeScan IP Holdings, LLC.
  • eka.care
  • BIOTRONIK SE & Co. KG

第 12 章:附录

简介目录
Product Code: HCIT8878

The global mHealth market reached US$ 61.65 billion in 2023 and is expected to reach US$ 162.20 billion by 2031, growing at a CAGR of 12.9% during the forecast period 2024-2031.

mHealth (mobile health) refers to the utilization of mobile phones and other wireless technologies in the field of healthcare. One of the primary applications of mHealth is to educate consumers about preventive healthcare services through mobile devices. Beyond education, mHealth also plays a vital role in various areas such as disease surveillance, treatment support, monitoring epidemic outbreaks, and managing chronic diseases. This diverse range of applications highlights the significant impact of mobile technology on enhancing healthcare delivery and improving patient outcomes.

Market Dynamics: Drivers & Restraints

Increasing usage of digital health solutions

Increasing usage of digital health solutions is expected to drive the mHealth market. This is due to the increasing technological advancements, increasing digital health solutions, and rising real-time results that are expected to drive the mHealth market growth. The growth of telehealth services is significantly boosting the adoption of mHealth solutions, particularly in highly advanced countries and regions. According to the National Institute of Health in April 2024, it is stated that Data from the United States suggests that only 38% of people over the age of 65 have used mHealth apps to monitor their health.

These digital health solutions facilitate remote consultations and ongoing health monitoring, thereby enhancing both accessibility and efficiency in healthcare delivery. Furthermore, innovations in wearable technology, including smartwatches and fitness trackers, are expanding the functionality of mHealth applications by enabling real-time tracking of essential health metrics. For instance, in October 2023, Cedars-Sinai announced that it is expanding virtual healthcare for patients in California through a new mobile app that allows individuals to quickly and easily access Cedars-Sinai experts for sick, chronic, and preventive care. Through the new virtual healthcare option Cedars-Sinai Connect, healthcare professionals are available 24/7 for urgent issues, and same-day appointments are accessible for primary care by reducing wait times.

This integration of telehealth and wearable devices is transforming the mHealth market, making it a vital component of modern healthcare that caters to the needs of diverse populations and improves overall health outcomes.

With the growing smartphone usage, the adoption of digital health solutions including mHealth solutions is expected to rise. There is a growing usage of smartphones among individuals. For instance, according to the Global Mobile Internet Connectivity, it is mentioned that mobile penetration is projected to increase to 6.3 billion by 2030, encompassing 74% of the global population.

Data privacy and security concerns

mHealth market's growth is significantly hindered by data privacy and security concerns arising from vulnerabilities in app design, insufficient protections for user data, developer knowledge gaps, regulatory compliance challenges, and user behavior. Addressing these issues is essential for fostering trust among consumers and promoting broader adoption of mHealth solutions. Without enhanced security measures and greater transparency regarding data handling practices, the potential advantages of mHealth technologies may go unrealized. Thus, the above factors could hinder the market growth by reducing the adoption of mHealth solutions.

Segment Analysis

The global mHealth market is segmented based on product type, application, end-user and region.

Product Type:

mHealth devices segment is expected to dominate the MHealth market share

mHealth devices segment is expected to dominate over mHealth apps. This is due to the growing adoption of wearables over the usage of mHealth apps. Individuals are often seeking convenience and effectiveness in the devices than mHealth apps. As consumers place greater emphasis on preventive healthcare, the demand for devices that support this approach is growing. mHealth devices are particularly effective in enabling users to proactively monitor their health. For instance, wearables can identify early signs of chronic conditions, allowing users to seek medical advice before problems worsen. These factors are encouraging users to adopt to mHealth devices.

Several companies are introducing advanced solutions that integrate advanced technologies and intelligence and are attracting consumers. For instance, in August 2022, GOQii introduced Smart Vital Ultra and GOQii Stream devices targeted at young adults and youth, encouraging them to lead a healthy and active lifestyle.

In November 2022, Sony launched new wearable motion trackers that let its wearer's experience metaverse up and close. Shipped in an oval-shaped charging case, the Mocopi consists of six differently colored motion trackers that have to be worn on the head, both wrists, hips, and ankles.

Geographical Analysis

North America is expected to hold a significant position in the mHealth market share

North America is expected to dominate the mHealth market due to the rising technological advancements, increasing adoption of mobile health apps and services and the presence of a large number of players in the region.

There is a widespread adoption of smartphones in the region. With the increasing number of smartphones, the number of mobile health apps installed and subscriptions are increasing.

With the growing geriatric population, the demand for mHealth solutions is rising because of their effectiveness in providing remote patient monitoring. There is a rising geriatric population in the region. For instance, the Population Reference Bureau in 2024 stated that the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group's share of the total population is projected to rise from 17% to 23%. The use of mHealth solutions increases with this rise.

The rising incidence of chronic diseases is also contributing to the growth of the market and is expected to increase the demand for mHealth solutions. The increasing incidence of these diseases is encouraging the market players to innovate new mHealth solutions which is contributing the market growth.

Collaborations between key companies and healthcare providers are leading to the development of advanced mobile health applications that cater to diverse health needs, from chronic disease management to fitness tracking. For instance, in June 2024, Cleveland Clinic and app developer FitNow, Inc. have launched the Cleveland Clinic Diet app, which offers health and diet advice built upon evidence-based nutrition science and clinical success, paired with a comprehensive food and fitness tracker. The app provides individualized guided support with the input of Cleveland Clinic health experts to help users make sustainable changes to their lifestyle and dietary habits for better health and well-being.

Asia-Pacific is growing at the fastest growing pace in the mHealth market

The rapid expansion of the mHealth market in the Asia-Pacific region is fueled by a combination of dynamic factors, making it a key player in the global landscape. One significant driver is the increasing prevalence of chronic diseases, which has heightened the demand for effective health management solutions.

Widespread adoption of mobile technology in healthcare, or mHealth, is now viewed as inevitable by more than half of doctors and healthcare payers in developed and emerging markets with over 60% in India. According to a new global study conducted for PwC Global Healthcare by the Economist Intelligence Unit (EIU), the pace of adoption will likely be led by emerging markets that rank highest among ten countries on a score of mHealth maturity.

Competitive Landscape

The major global players in the mHealth market include Medtronic, OMRON Healthcare, Inc., AliveCor, Inc., AirStrip Technologies, Inc, AgaMatrix, F. Hoffmann-La Roche AG, Abbott, LifeScan IP Holdings, LLC., eka.care, and BIOTRONIK SE & Co. KG among others.

  • Why Purchase the Report?
  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global MHealth market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing usage of digital health solutions
    • 4.1.2. Restraints
      • 4.1.2.1. Data privacy and security concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. mHealth Apps*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. General Health & Fitness Apps
    • 6.2.4. Chronic Disease Management Apps
    • 6.2.5. Women's Health Apps
    • 6.2.6. Other Healthcare Apps
  • 6.3. mHealth Devices
    • 6.3.1. Blood Glucose Monitors
    • 6.3.2. Blood Pressure Monitors
    • 6.3.3. Pulse Oximetry
    • 6.3.4. Neurological Monitors
    • 6.3.5. Cardiac Monitors
    • 6.3.6. Apnea and Sleep Monitors
    • 6.3.7. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiovascular Diseases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diabetes
  • 7.4. Fetal Monitoring
  • 7.5. Respiratory Diseases
  • 7.6. Neurology
  • 7.7. Nutrition & Fitness
  • 7.8. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Healthcare Providers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Patients/Consumers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. OMRON Healthcare, Inc.
  • 11.3. AliveCor, Inc.
  • 11.4. AirStrip Technologies, Inc
  • 11.5. AgaMatrix
  • 11.6. F. Hoffmann-La Roche AG
  • 11.7. Abbott
  • 11.8. LifeScan IP Holdings, LLC.
  • 11.9. eka.care
  • 11.10. BIOTRONIK SE & Co. KG

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us